Literature DB >> 9078395

Immunocytochemical evidence for differential subcellular localization of 5 alpha-reductase isoenzymes in human tissues.

G Aumüller1, W Eicheler, H Renneberg, K Adermann, P Vilja, W G Forssmann.   

Abstract

To contrast the previously described distribution of 5 alpha-reductase isoenzyme 2 in human organs we have raised synthetic C-terminal peptides of human 5 alpha-reductase isoenzyme 1 (h 5 alpha r1) and isoenzyme 2 (h 5 alpha r2) respectively, and studied the cellular and subcellular distribution of both isoforms of this key enzyme of testosterone metabolism using the human prostate gland as a reference. h 5 alpha r1, which in Western blots of human prostatic proteins had an apparent molecular weight of 23 kDa, was localized immunohistochemically in the nucleus of prostatic epithelial and stromal cells. Ultrastructurally, it was closely associated with the nuclear matrix. The apparent molecular weight of h 5 alpha r2 was 26 kDa in Western blotting of human prostatic proteins. In immunohistochemically processed sections, it was seen in the cytoplasm of prostatic epithelial as well as stromal cells. An organ screening with genital and extragenital tissues of males and females was performed and to elucidate the distribution of the isoenzymes. Presence of both isoenzymes was demonstrated for a number of tissues, including the central nervous system, the urogenital tract, the respiratory tract, the gastrointestinal tract, skin, and the endocrine system. The divergent localization of 5 alpha-reductase isoenzymes points to potentially different functions in various organs. In view of the nuclear localization of isoenzyme 1, its close spatial relationship with the androgen receptor is presumed to indicate a close association with the receptor mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9078395     DOI: 10.1159/000147852

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  14 in total

1.  Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

Authors:  M Paola Castelli; Alberto Casti; Angelo Casu; Roberto Frau; Marco Bortolato; Saturnino Spiga; Maria Grazia Ennas
Journal:  Psychoneuroendocrinology       Date:  2012-07-08       Impact factor: 4.905

2.  Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.

Authors:  Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Paola Muzi; Carlo Vicentini; Mauro Bologna
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-14       Impact factor: 4.553

3.  5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activity.

Authors:  Baerbel U Panter; Joachim Jose; Rolf W Hartmann
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

Authors:  K S Banu; P Govindarajulu; M M Aruldhas
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

Review 6.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

7.  Secondary infertility due to use of low-dose finasteride.

Authors:  Ahmet Şalvarci; Okan Istanbulluoğlu
Journal:  Int Urol Nephrol       Date:  2012-10-16       Impact factor: 2.370

Review 8.  Drugs for benign prostatic hypertrophy.

Authors:  Manasi Jiwrajka; William Yaxley; Sachinka Ranasinghe; Marlon Perera; Matthew J Roberts; John Yaxley
Journal:  Aust Prescr       Date:  2018-10-01

9.  The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases.

Authors:  Faris Azzouni; Alejandro Godoy; Yun Li; James Mohler
Journal:  Adv Urol       Date:  2011-12-25

10.  5-alpha-reductase and the development of the human prostate.

Authors:  C Radmayr; A Lunacek; C Schwentner; J Oswald; H Klocker; G Bartsch
Journal:  Indian J Urol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.